Hydroxychloroquine and Azithromycin Treatment of Hospitalized Patients Infected with SARS-CoV-2 in Senegal from March to October 2020

As of today, little data is available on COVID-19 in African countries, where the case management relied mainly on a treatment by association between hydroxychloroquine (HCQ) and azithromycin (AZM). This study aimed to understand the main clinical outcomes of COVID-19 hospitalized patients in Senega...

Descripción completa

Detalles Bibliográficos
Autores principales: Taieb, Fabien, Mbaye, Khardiata Diallo, Tall, Billo, Lakhe, Ndèye Aïssatou, Talla, Cheikh, Thioub, Daouda, Ndoye, Amadou Moustapha, Ka, Daye, Gaye, Aboubacry, Cissé Diallo, Viviane Marie-Pierre, Dia, Ndongo, Ba, Pape Samba, Cissé, Mamadou, Diop, Moustapha, Diagne, Cheikh Tidiane, Fortes, Louise, Diop, Mamadou, Fall, Ndèye Maguette, Sarr, Fatoumata Diène, Diatta, Margarite, Barry, Mamadou Aliou, Badiane, Aboubakar Sidikh, Seck, Abdoulaye, Dubrous, Philippe, Faye, Ousmane, Vigan-Womas, Inès, Loucoubar, Cheikh, Sall, Amadou Alpha, Seydi, Moussa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269162/
https://www.ncbi.nlm.nih.gov/pubmed/34209237
http://dx.doi.org/10.3390/jcm10132954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269162/
https://www.ncbi.nlm.nih.gov/pubmed/34209237
http://dx.doi.org/10.3390/jcm10132954

Ejemplares similares